Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miroslav Backonja

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Pain Medicine (Malden, Mass.)|May 20, 2017
Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid DepressionStuart L Silverman, Miroslav Backonja, Lynne Pauer, et al.
The American Journal of Drug and Alcohol Abuse|May 24, 2016
Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid usersMiroslav Backonja, Lynn R Webster, Beatrice Setnik, et al.
Pain Medicine (Malden, Mass.)|July 31, 2007
Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomesDavid G Armstrong, Amy S Chappell, Trong K Le, et al.
The Clinical Journal of Pain|April 24, 2007
Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry studyRussell K Portenoy, John T Farrar, Misha-Miroslav Backonja, et al.
The Clinical Journal of Pain|August 21, 2009
Quantitative sensory testing and mapping: a review of nonautomated quantitative methods for examination of the patient with neuropathic painDavid Walk, Nalini Sehgal, Tobias Moeller-Bertram, et al.
Journal of Pain Research|August 26, 2021
Classification of Qualitative Fieldnotes Collected During Quantitative Sensory Testing: A Step Towards the Development of a New Mixed Methods Approach in Pain ResearchMartine Bordeleau, Guillaume Léonard, Lynn Gauthier, et al.
Spine|May 13, 2010
Efficacy and safety of duloxetine in patients with chronic low back painVladimir Skljarevski, Durisala Desaiah, Hong Liu-Seifert, et al.
Scientific Reports|December 25, 2019
Reduced TRPM8 expression underpins reduced migraine risk and attenuated cold pain sensation in humansNarender R Gavva, Robert Sandrock, Gregory E Arnold, et al.
Pain|December 28, 2010
Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic painDavid J Hewitt, Tony W Ho, Bradley Galer, et al.
Steroids|March 11, 2018
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomesEric P Hoffman, Valerie Riddle, Maxime A Siegler, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Pain Medicine (Malden, Mass.)|May 20, 2017
Effect of Baseline Characteristics on the Pain Response to Pregabalin in Fibromyalgia Patients with Comorbid DepressionStuart L Silverman, Miroslav Backonja, Lynne Pauer, et al.
The American Journal of Drug and Alcohol Abuse|May 24, 2016
Intravenous abuse potential study of oxycodone alone or in combination with naltrexone in nondependent recreational opioid usersMiroslav Backonja, Lynn R Webster, Beatrice Setnik, et al.
Pain Medicine (Malden, Mass.)|July 31, 2007
Duloxetine for the management of diabetic peripheral neuropathic pain: evaluation of functional outcomesDavid G Armstrong, Amy S Chappell, Trong K Le, et al.
The Clinical Journal of Pain|April 24, 2007
Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry studyRussell K Portenoy, John T Farrar, Misha-Miroslav Backonja, et al.
The Clinical Journal of Pain|August 21, 2009
Quantitative sensory testing and mapping: a review of nonautomated quantitative methods for examination of the patient with neuropathic painDavid Walk, Nalini Sehgal, Tobias Moeller-Bertram, et al.
Journal of Pain Research|August 26, 2021
Classification of Qualitative Fieldnotes Collected During Quantitative Sensory Testing: A Step Towards the Development of a New Mixed Methods Approach in Pain ResearchMartine Bordeleau, Guillaume Léonard, Lynn Gauthier, et al.
Spine|May 13, 2010
Efficacy and safety of duloxetine in patients with chronic low back painVladimir Skljarevski, Durisala Desaiah, Hong Liu-Seifert, et al.
Scientific Reports|December 25, 2019
Reduced TRPM8 expression underpins reduced migraine risk and attenuated cold pain sensation in humansNarender R Gavva, Robert Sandrock, Gregory E Arnold, et al.
Pain|December 28, 2010
Impact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic painDavid J Hewitt, Tony W Ho, Bradley Galer, et al.
Steroids|March 11, 2018
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomesEric P Hoffman, Valerie Riddle, Maxime A Siegler, et al.
Pageof 8